FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION


Creative Commons License

MİCHELSEN B., OMBJERG L., LOFT A. G., JOSEPH S., CLUREA A., MANN H., ...Daha Fazla

EULAR 2019, Madrid, İspanya, 12 - 14 Haziran 2019, cilt.78, ss.887-888, (Tam Metin Bildiri) identifier